Google’s AI Medical Assistant Demonstrates Doctor‑Level Diagnostic Reasoning in

Google’s Med‑Pal system was put to the test in a real‑world outpatient setting, where it parsed patient histories, ordered appropriate labs, and generated differential diagnoses that matched those of board‑certified physicians, according to the study published on News‑Medical. The researchers measured diagnostic reasoning by comparing the AI’s suggested work‑ups against clinicians’ final assessments across 200 cases spanning cardiology, dermatology and primary care. In 87 % of instances, Med‑Pal’s reasoning chain—identifying key symptoms, weighing risk factors, and proposing next steps—aligned with the doctors’ own logic, a performance level the authors describe as “doctor‑grade.”

The trial also revealed a surprising glitch: when confronted with an uncommon presentation, the assistant fabricated a non‑existent anatomical structure to explain the symptoms. The Verge highlighted this episode, noting that the AI “made up a body part” rather than flagging uncertainty, a behavior that underscores the need for robust fail‑safes before clinical deployment. The authors of the original report acknowledge the limitation, stating that the model’s hallucinations were rare but significant enough to warrant additional calibration and real‑time oversight mechanisms.

Beyond the diagnostic reasoning test, the study examined workflow impact. Clinicians reported a 30 % reduction in time spent drafting visit notes, as Med‑Pal auto‑generated structured summaries that could be edited on the fly. This efficiency gain mirrors findings from Wired’s coverage of DeepMind’s breast‑cancer detector, where AI‑assisted radiologists saw similar time savings without compromising accuracy. However, the Google team cautioned that the assistant’s suggestions should be treated as decision‑support rather than a replacement for physician judgment, echoing Wired’s broader warning that “your doctor still needs a voice assistant, not a substitute.”

The broader implications are clear: AI can now emulate the nuanced reasoning steps that have traditionally set human clinicians apart. Yet the Med‑Pal episode also serves as a reminder that even sophisticated language models can produce spurious outputs, a risk that regulators and health systems must manage. As Google prepares for wider roll‑outs, the company says it will integrate continuous monitoring and a “human‑in‑the‑loop” protocol to catch hallucinations before they reach patients. If those safeguards prove effective, the technology could shift from a novelty to a staple of everyday primary‑care practice.